Fungal urinary tract infections are caused almost exclusively by Candida species, a type of yeast that normally lives on your skin and in your gut without causing problems. When something disrupts the body’s natural defenses, Candida can overgrow and colonize the urinary tract. The three species responsible for the vast majority of cases are Candida albicans (about 49% of cases), Candida glabrata (21%), and Candida tropicalis (14%), though the balance between species has been shifting in recent years.
Unlike bacterial UTIs, which are extremely common in otherwise healthy people, fungal UTIs occur primarily in hospital settings and in people with specific underlying conditions. Understanding the causes can help you recognize whether you might be at risk.
How Candida Reaches the Urinary Tract
Candida can infect the urinary tract through two distinct routes. The more common pathway is ascending infection, where yeast travels upward from the genitals into the urethra and bladder. This is the same route bacteria typically take to cause standard UTIs. The second route is through the bloodstream: Candida circulating in the blood can settle in the kidneys and work its way down into the urinary system. This blood-borne route is more closely associated with kidney involvement and tends to occur in people who are already seriously ill, particularly those in intensive care units.
Broad-Spectrum Antibiotics
The single most important trigger for fungal UTIs is prolonged use of broad-spectrum antibiotics. These medications kill harmful bacteria, but they also wipe out the protective bacteria that normally keep Candida populations in check. Without that competition, yeast can multiply rapidly and colonize areas it wouldn’t normally dominate, including the urinary tract. Studies consistently find that broad-spectrum antibiotic use is one of the strongest predictors separating patients who develop Candida UTIs from those who develop bacterial ones.
Urinary Catheters and Biofilms
Indwelling urinary catheters are a major contributor to fungal UTIs, particularly when they remain in place for a week or longer. Candida cells attach to the catheter surface and form biofilms, which are structured communities of yeast encased in a protective matrix. This matrix shields the yeast from both the immune system and antifungal medications, making catheter-associated infections particularly stubborn.
The biofilm develops in stages. Yeast cells first attach to the catheter surface using specialized proteins on their cell walls. They then multiply and shift shape, forming long filament-like structures that act as scaffolding for the growing colony. Eventually the biofilm matures into a three-dimensional structure that can continuously release yeast cells into the urinary tract. Candida albicans and Candida parapsilosis are the most prolific biofilm producers on catheters, which is one reason catheter removal is often a critical part of treatment.
Diabetes and High Blood Sugar
People with diabetes face a significantly higher risk of fungal UTIs. The connection involves several overlapping factors. When blood sugar is poorly controlled, excess glucose spills into the urine, creating a nutrient-rich environment where Candida thrives. Hyperglycemia also impairs immune cell function, reducing the body’s ability to fight off fungal colonization. On top of that, diabetes-related nerve damage can affect bladder function, leading to incomplete emptying and urinary stasis, both of which give yeast more time to establish itself.
Research from Iran found that uncontrolled diabetes, elevated fasting blood sugar, and glucose in the urine were all independently associated with Candida in the urinary tract. The relationship appears to be driven more by immune dysfunction and the local urinary environment than by blood sugar levels alone.
Other Risk Factors
Several additional conditions create vulnerability to fungal UTIs:
- Weakened immune system: Immunosuppressive therapies, organ transplants, HIV, and cancer treatment all reduce the body’s ability to keep Candida in check.
- Prolonged hospitalization: Hospital stays of 14 days or longer are significantly associated with Candida UTIs. Longer stays mean more exposure to antibiotics, catheters, and other invasive procedures.
- Intensive care: ICU patients face the highest rates because they typically have multiple risk factors simultaneously: catheters, antibiotics, weakened immunity, and serious underlying illness.
- Newborns: In neonatal intensive care units, Candida species account for as many as 42% of hospital-acquired UTIs. Candida parapsilosis is an increasingly common cause in this age group.
How Fungal UTIs Feel Different
Fungal UTIs can produce many of the same symptoms as bacterial UTIs: frequent urination, urgency, pain or burning during urination, and cloudy or discolored urine. The challenge is that many fungal UTIs, especially in catheterized patients, produce minimal or no symptoms at all. Candida may simply show up in a urine culture without causing obvious discomfort, a condition called asymptomatic candiduria.
When symptoms do appear, they can overlap with genital yeast infections, which sometimes creates confusion. A genital yeast infection typically causes itching, swelling, and a thick, clumpy discharge, while a urinary tract infection centers on urinary urgency and pain. It’s possible to have both at the same time, since the same organism is responsible for each.
How Fungal UTIs Are Diagnosed
Diagnosing a fungal UTI is less straightforward than diagnosing a bacterial one. There is no single universally agreed-upon threshold for how much Candida in the urine counts as a true infection. Different guidelines use cutoffs ranging from 1,000 to 100,000 yeast cells per milliliter of urine, and the thresholds may differ for men and women. Microscopic examination of the urine can help by identifying patients with higher fungal loads, generally picking up cases above 10,000 cells per milliliter.
The difficulty lies in distinguishing between contamination, harmless colonization, and actual infection. A single positive urine culture doesn’t necessarily mean treatment is needed. Clinicians typically look for symptoms like fever, urinary pain, or urgency alongside a positive culture before diagnosing a true fungal UTI.
Treatment Approach
The first step in treating a fungal UTI is addressing the underlying cause whenever possible. If a urinary catheter is in place, removing or replacing it can resolve the infection on its own by eliminating the surface where biofilm has formed. Similarly, narrowing or stopping unnecessary antibiotics allows normal protective bacteria to recover and compete with Candida.
When antifungal medication is needed, oral antifungal drugs are the standard first-line treatment for urinary Candida infections. Treatment continues until there’s clear evidence the infection has resolved, though the duration varies depending on how severe the infection is and whether the kidneys are involved. Infections caused by Candida glabrata can be more difficult to treat because this species is more likely to resist common antifungal medications, which is one reason identifying the specific Candida species matters.
For people with diabetes, improving blood sugar control is an essential part of both treatment and prevention. Reducing glucose in the urine removes the fuel source that helps Candida establish itself in the first place.